Quick Answer
Dianthus Therapeutics, Inc. /DE/ reported Common Stock Shares Outstanding of 43.22 million shares for the year ending 2025.
- Dianthus Therapeutics, Inc. /DE/ showed an increase of +38.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Dianthus Therapeutics, Inc. /DE/'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Dianthus Therapeutics, Inc. /DE/'s Common Stock Shares Outstanding has grown by 1,738.3%.
- Historical annual values: Fiscal year 2025: 43.22 million shares | Fiscal year 2024: 31.12 million shares | Fiscal year 2023: 14.82 million shares | Fiscal year 2022: 875,279 shares | Fiscal year 2021: 58.80 million shares | Fiscal year 2020: 48.53 million shares | Fiscal year 2019: 39.26 million shares | Fiscal year 2018: 33.31 million shares | Fiscal year 2017: 2.35 million shares.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: